• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养的小鼠足细胞中肾素-血管紧张素系统酶活性的表征

Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.

作者信息

Velez Juan Carlos Q, Bland Alison M, Arthur John M, Raymond John R, Janech Michael G

机构信息

Department of Research, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA.

出版信息

Am J Physiol Renal Physiol. 2007 Jul;293(1):F398-407. doi: 10.1152/ajprenal.00050.2007. Epub 2007 Apr 11.

DOI:10.1152/ajprenal.00050.2007
PMID:17429035
Abstract

Intraglomerular ANG II has been linked to glomerular injury. However, little is known about the contribution of podocytes (POD) to intraglomerular ANG II homeostasis. The aim of the present study was to examine the processing of angiotensin substrates by cultured POD. Our approach was to use matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for peptide determination from conditioned cell media and customized AQUA peptides for quantification. Immortalized mouse POD were incubated with 1-2 microM ANG I, ANG II, or the renin substrate ANG-(1-14) for different time intervals and coincubated in parallel with various inhibitors. Human mesangial cells (MES) were used as controls. POD incubated with 1 microM ANG I primarily formed ANG-(1-9) and ANG-(1-7). In contrast, MES incubated with ANG I primarily generated ANG II. In POD, ANG-(1-7) was the predominant product, and its formation was inhibited by a neprilysin inhibitor. Modest angiotensin-converting enzyme (ACE) activity was also detected in POD, although only after cells were incubated with 2 microM ANG I. In addition, we observed that POD degraded ANG II into ANG III and ANG-(1-7). An aminopeptidase A inhibitor inhibited ANG III formation, and an ACE2 inhibitor led to ANG II accumulation. Furthermore, we found that POD converted ANG-(1-14) to ANG I and ANG-(1-7). This conversion was inhibited by a renin inhibitor. These findings demonstrate that POD express a functional intrinsic renin-angiotensin system characterized by neprilysin, aminopeptidase A, ACE2, and renin activities, which predominantly lead to ANG-(1-7) and ANG-(1-9) formation, as well as ANG II degradation. These findings may reflect a specific role of POD in maintenance of intraglomerular renin-angiotensin system balance.

摘要

肾小球内的血管紧张素II(ANG II)与肾小球损伤有关。然而,关于足细胞(POD)对肾小球内ANG II稳态的贡献知之甚少。本研究的目的是检测培养的POD对血管紧张素底物的加工处理情况。我们的方法是使用基质辅助激光解吸/电离飞行时间(MALDI-TOF)质谱法测定条件细胞培养基中的肽段,并使用定制的AQUA肽进行定量分析。将永生化小鼠POD与1-2微摩尔的ANG I、ANG II或肾素底物ANG-(1-14)孵育不同时间间隔,并与各种抑制剂平行共孵育。人系膜细胞(MES)用作对照。用1微摩尔ANG I孵育的POD主要生成ANG-(1-9)和ANG-(1-7)。相比之下,用ANG I孵育的MES主要生成ANG II。在POD中,ANG-(1-7)是主要产物,其形成受到中性内肽酶抑制剂的抑制。在POD中也检测到适度的血管紧张素转换酶(ACE)活性,不过只有在细胞与2微摩尔ANG I孵育后才检测到。此外,我们观察到POD将ANG II降解为ANG III和ANG-(1-7)。氨肽酶A抑制剂抑制ANG III的形成,而ACE2抑制剂导致ANG II积累。此外,我们发现POD将ANG-(1-14)转化为ANG I和ANG-(1-7)。这种转化受到肾素抑制剂的抑制。这些发现表明,POD表达一种功能性的内在肾素-血管紧张素系统,其特征在于具有中性内肽酶、氨肽酶A、ACE2和肾素活性,主要导致ANG-(1-7)和ANG-(1-9)的形成以及ANG II的降解。这些发现可能反映了POD在维持肾小球内肾素-血管紧张素系统平衡中的特定作用。

相似文献

1
Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.培养的小鼠足细胞中肾素-血管紧张素系统酶活性的表征
Am J Physiol Renal Physiol. 2007 Jul;293(1):F398-407. doi: 10.1152/ajprenal.00050.2007. Epub 2007 Apr 11.
2
Enzymatic processing of angiotensin peptides by human glomerular endothelial cells.人肾小球内皮细胞对血管紧张肽的酶促加工。
Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1583-94. doi: 10.1152/ajprenal.00087.2012. Epub 2012 Mar 28.
3
Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.氨基肽酶-A 在心肌梗死后血管紧张素-(1-7)代谢中的新作用。
Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1032-40. doi: 10.1152/ajpheart.00911.2013. Epub 2014 Jan 24.
4
New mass spectrometric assay for angiotensin-converting enzyme 2 activity.用于血管紧张素转换酶2活性的新型质谱检测法。
Hypertension. 2006 May;47(5):1010-7. doi: 10.1161/01.HYP.0000215588.38536.30. Epub 2006 Apr 3.
5
Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli.血管紧张素I在分离的大鼠肾小球中大量转化为血管紧张素(1-7)和血管紧张素(2-10)。
Hypertension. 2009 May;53(5):790-7. doi: 10.1161/HYPERTENSIONAHA.109.128819. Epub 2009 Mar 16.
6
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.绵羊肾近端小管、尿液和血清中的血管紧张素代谢:血管紧张素 II 依赖 ACE2 加工的证据
Am J Physiol Renal Physiol. 2007 Jan;292(1):F82-91. doi: 10.1152/ajprenal.00139.2006. Epub 2006 Aug 8.
7
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.脑啡肽酶是鼠类和人类肾脏中肾素-血管紧张素系统替代途径激活的介质。
Sci Rep. 2016 Sep 21;6:33678. doi: 10.1038/srep33678.
8
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.血管紧张素转换酶(ACE)、其同源物ACE2及中性肽链内切酶在血管紧张素肽代谢中的评估
Biochem J. 2004 Oct 1;383(Pt 1):45-51. doi: 10.1042/BJ20040634.
9
Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis.血浆和肾脏血管紧张素肽:氨肽酶A/血管紧张素III轴的重要性。
Am J Hypertens. 2015 Dec;28(12):1418-26. doi: 10.1093/ajh/hpv054. Epub 2015 May 11.
10
Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.脑内血管紧张素转换酶:血管紧张素转换酶2在小鼠体内加工血管紧张素II中的作用
Exp Physiol. 2008 May;93(5):665-75. doi: 10.1113/expphysiol.2007.040311. Epub 2008 Feb 8.

引用本文的文献

1
Aminopeptidase A Effect on Angiotensin Peptides and Their Blood Pressure Action.氨肽酶A对血管紧张素肽及其血压作用的影响。
Int J Mol Sci. 2025 Jul 21;26(14):6990. doi: 10.3390/ijms26146990.
2
Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans.急性肾损伤与城市新奥尔良的 2019 年冠状病毒病相关。
Kidney360. 2020 May 13;1(7):614-622. doi: 10.34067/KID.0002652020. eCollection 2020 Jul 30.
3
Proteinuria in COVID-19.新型冠状病毒肺炎中的蛋白尿
Clin Kidney J. 2021 Mar 26;14(Suppl 1):i40-i47. doi: 10.1093/ckj/sfab036. eCollection 2021 Mar.
4
COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care.COVID-19 肺外疾病 - COVID-19 对肾脏病学护理的影响。
Dis Mon. 2020 Sep;66(9):101057. doi: 10.1016/j.disamonth.2020.101057. Epub 2020 Jul 25.
5
AKI and Collapsing Glomerulopathy Associated with COVID-19 and High-Risk Genotype.与 COVID-19 和高危基因型相关的急性肾损伤和肾小球塌缩症。
J Am Soc Nephrol. 2020 Aug;31(8):1688-1695. doi: 10.1681/ASN.2020050558. Epub 2020 Jun 19.
6
Is the kidney a target of SARS-CoV-2?肾脏是否是 SARS-CoV-2 的靶器官?
Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1454-F1462. doi: 10.1152/ajprenal.00160.2020. Epub 2020 May 15.
7
A study of the properties of Gaussian mixture model for stable isotope standard quantification in MALDI-TOF MS.用于基质辅助激光解吸电离飞行时间质谱中稳定同位素标准定量的高斯混合模型特性研究
Commun Stat Simul Comput. 2019;48(6):1637-1650. doi: 10.1080/03610918.2017.1422748. Epub 2018 Jan 30.
8
Role of Podocyte Injury in Glomerulosclerosis.足细胞损伤在肾小球硬化中的作用。
Adv Exp Med Biol. 2019;1165:195-232. doi: 10.1007/978-981-13-8871-2_10.
9
Proteomic Analysis of Urine from California Sea Lions ( Zalophus californianus): A Resource for Urinary Biomarker Discovery.加利福尼亚海狮(Zalophus californianus)尿液的蛋白质组学分析:尿液生物标志物发现的资源。
J Proteome Res. 2018 Sep 7;17(9):3281-3291. doi: 10.1021/acs.jproteome.8b00416. Epub 2018 Aug 28.
10
Angiotensin II Modulates Podocyte Glucose Transport.血管紧张素II调节足细胞葡萄糖转运。
Front Endocrinol (Lausanne). 2018 Jul 24;9:418. doi: 10.3389/fendo.2018.00418. eCollection 2018.